Methylation of Cell-Free circulating DNA From Plasma as a Biomarker for Cancer Diagnosis and Treatment MonitoringTuesday, 26 April 2011 at 11:15 Add to Calendar ▼2011-04-26 11:15:002011-04-26 12:15:00Europe/LondonMethylation of Cell-Free circulating DNA From Plasma as a Biomarker for Cancer Diagnosis and Treatment MonitoringEpigenetics World Congress in BostonBostonSELECTBIOenquiries@selectbiosciences.com A novel technology (Methylation Detection or MethDet) can assess genome-wide methylation and yet requires as little as 20 cells. Applications of MethDet for biomarker development in the areas of detection, diagnosis, and monitoring will be discussed. |